Transgene Biotek Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 23	Sep ' 22	Mar ' 22	Sep ' 21	Sep ' 20

Sales

0.14

0.06

0.09

-

-

Operating profit

-0.24

-0.68

-0.22

-0.25

-0.32

Interest

0.06

0.09

0.11

0.11

0.13

Gross profit

-0.22

-0.68

-0.20

-0.27

-0.36

EPS (Rs)

-0.03

-0.42

-0.68

-0.69

-0.70

Other income

0.09

0.09

0.12

0.09

0.09

Stock adjustment

-

-

-0.07

-

-

Raw material

-

-

0.02

0.01

0.01

Power and fuel

-

-

-

-

-

Employee expenses

0.16

0.15

0.16

0.13

0.15

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

0.23

0.58

0.20

0.11

0.15

Provisions made

-

-

-

-

-

Depreciation

0.05

2.48

4.98

4.94

4.95

Taxation

-

-

-

-

-

Net profit / loss

-0.26

-3.16

-5.19

-5.21

-5.31

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

75.77

75.77

75.77

75.77

75.77

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

-166.25

-1233.73

-254.23

-14591.29

-

GPM (%)

-93.64

-478.07

-97.52

-305.41

-

NPM (%)

-113.50

-2211.68

-2472.36

-5832.99

-